Inhibition of hepatocellular carcinoma growth by blockade of glycosphingolipid synthesis

SUPPLEMENTARY MATERIALS
Sphingolipid extraction, mass spectrometry, and sialidase treatment of acidic GSL One part of liver and tumor corresponding to ~50mg dry tissue has been extracted as described [1] . Isolated sphingolipids including GSLs, ceramides, and sphingomyelins were investigated by thin layer chromatography (TLC) and mass spectrometry (MS) [1] . For the detection of 0-series gangliosides (GM1b and GD1α) in tumor tissue, three aliquots of the extracts from representative GSL-deficient and control tissues corresponding to 2mg tissue dry weight were loaded on a TLC plate (Merck, Darmstadt, Germany) together with an extract from bone marrow-derived dendritic cells as a control. The TLC plate was divided into 3 parts. One was stained with orcinol reagent to visualize all GSLs. The remaining plates were fixed with 5% polyisobutylmethacrylate (Sigma, Munich, Germany) in chloroform which was 1:10 diluted in n-hexane. The second plate remained untreated and the third plate was treated with sialidase accordingly as described [2] . Thereafter, the plate was blocked with 1% BSA in PBS for 10min and subsequently washed 4 times with neuraminidase digestion buffer (0.2M sodium acetate, 2mM CaCl 2 buffer, pH 5.2). The TLC plate was covered with 0.05u/ml of Vibrio cholera sialidase (Sigma) in digestion buffer for 6h at RT. Sialidase was removed by 4 times washing with PBS/0.05% Tween 20. For the detection of GA1 as cleavage product from acidic GSLs of the 0-series, both untreated-and sialidase treated plates were first blocked with 1% BSA in PBS for 30min. Then the plates were incubated with an affinity purified [3] anti-GA1 antibody (Acris, Herford, Germany) 1:50 diluted in 1% BSA in PBS at 4°C overnight. The plates were washed five times with PBS/0.05% Tween-20 and incubated with secondary 1:500 diluted horseradish peroxidase-linked goat anti-rabbit antibodies (Dianova, Hamburg, Germany) in 1% BSA/PBS for 4h at RT. After washing for five times, positive bands were detected using Sigma Fast BCIP (Sigma). antibody raised in mice which has been affinity purified on a GM2-octylsepharose column [3] . 5x10 4 Genz or Ugcg guide RNA-treated Hepa cells were transferred on top of glass coverslips (Marienfeld, Germany) in 6 well plates. The cells were allowed to attach overnight. An equal volume of 4% PFA in PBS was added to the 6-well plate and Hepa cells prefixed for 10min followed by another fixation step with 4% PFA in PBS for 10min. The coverslips were washed three times with PBS for 5min and permeabilized/blocked with 0.01% triton X-100 (Sigma) in PBS at room temperature for 10min (note, higher triton X-100 concentrations or extended treatment time may lead to a dislocation of glycolipids). Blocking was subsequently performed with 1% fat free milk powder in PBS for 30min at room temperature. For the GM2/tubulin staining, the affinity purified anti-GM2 antibody was 1:50 diluted in 1% milk powder in PBS and placed on top of the coverslips over night at 4°C. After three washing steps each with PBS for 5 min, cells were covered with antimouse AF-488 (Life Technologies, Darmstadt, Germany), 1:200 in 1% milk powder in PBS at RT for 1h. Coverslips were washed as before, stained with rabbit anti-tubulin (Cell Signaling, Danvers, MA, USA, #2128), 1:200 in 1% milk powder in PBS at RT for 1h. After washing, secondary anti-rabbit AF 594 (Life Technologies), 1:200 in 1% milk powder in PBS was added to the coverslips respectively at RT for 1h.
Immunohistochemistry and immunofluorescence
For the Rab11/GM2 staining, coverslips were treated as described above and first stained with rabbit anti-Rab11 (Cell Signaling, #5589), 1:20 in 1% milk powder in PBS at RT for 1h. After washing, secondary anti-rabbit AF 488 (Life Technologies), 1:200 in 1% milk powder in PBS was added to the coverslips respectively at RT for 1h. After washing, cells were covered by the affinity purified anti-GM2 antibody as described above over night at 4°C. After 3 washing steps each with PBS for 5 min, cells were covered with anti-mouse AF-594 (Life Technologies), 1:200 in 1% milk powder in PBS at RT for 1h. Coverslips were washed as before and for nuclear staining covered with diluted DAPI solution (0.1μg/ml) in 1% milk powder in PBS for 10 min. After a final washing step with PBS, coverslips were embedded in fluorescent mounting medium (DAKO). For staining of actin filaments cells were fixed as described above and pretreated with 0.1% triton X-100 at RT for 10min. After blocking with 1% milk powder in PBS for 30min, actin was stained with Phalloidin TxRed (Biotrend, Cologne, Germany), 1:200 in 1% milk powder in PBS at RT for 1h. Coverslips were washed and nuclear staining performed as described before. Images were taken with a Keyence BZ-9000 fluorescent microscope (Neu-Isenburg, Germany).
Cultivation and transfection of Hepa 1-6 cells with small interfering RNAs (siRNAs)
5 Hepa 1-6 primary mouse hepatoma cells (ATCC, Manassas, Virginia, USA) in 4 ml culture medium (DMEM with high glucose and glutamine, 10% FCS, Pen/Strep, and Hepes, all from Life Technologies) were transfected with a mix containing 1ml DMEM w/o FCS, 20μl Hiperfect (Qiagen, Hilden, Germany), and 6.3μl specific siRNA; Ugcg siRNA si01461551 (20μM) as well as control siRNA si03650318, 20μM; all from Qiagen) in a 10cm culture dish. 5ml culture medium was added after 24h. Cells were cultivated for further 2d and counted. Cells were split in equal number and retransfected as described before for another 3d. For determination of the proliferation, cells were harvested and counted.
GSL depletion in Hepa 1-6 cells using CRISPR/ Cas9 technology; cloning of the Ugcg guide sequence into the CRISPR/Cas9 expression vector
Plasmid pX459 (Addgene, Cambridge, MA, USA) with combined guide RNA/Cas9 expression sequence as well as puromycin and ampicillin resistance has been used for insertion of the Ugcg guide oligos. The vector (5μg) was digested with 10u of the enzyme Bbs I (Thermo Scientific, Waltham, MA, USA) at 37°C for 16h. The DNA was purified using a PCR-purification Kit (Qiagen). The guide oligos used were:
Ugcg guide 1 forward: 5'-GTTCGGCTTCGTGC TCTTCG-3 ' and Ugcg guide 1 reverse: 5'-CGAAGAGCACGA AGCCGAAC-3' as well as Ugcg guide 2 forward: 5'-GAATCAGATG ACAGAGAAAG-3'
and Ugcg guide 2 reverse: 5'-CTTTCTCTGTCA TCTGATTC-3', including the 5'-and 3'-Bbs I overhangs, respectively, were dissolved at a concentration of 150μM. 25μl of the respective forward and reverse oligonucleotide was mixed and annealed (95°C, 4'; 70°C, 10'; followed by cooling down the mixture in a thermomixer (Eppendorf, Hamburg, Germany) to room temperature). For oligo insertion, ~100ng of the purified expression vector, 10μl (~10μg) of the annealed oligo and 1u of T4-ligase and ligase buffer (Life Technologies) in a total volume of 20μl (ad. ddH 2 O) were used. In addition, a control ligation without ligase was performed. Ligations were performed at 16°C for 16h. Due to the excess of oligonucleotides (> 40000 fold, mol/mol), dephosphorylation of the plasmid was not necessary to inhibit vector religation. Subsequently, DH5α E. coli (Life Technologies) were transformed with 5μl of the ligation mixtures according to the manufacturer's protocol and spread on LB agar gel plates with 100μg/ml ampicillin. The plates were incubated at 37°C for 16h. Minipreps of single colonies were performed in 5ml LB medium with 100μg/ml ampicillin at 37°C in a bacteria shaker for 16h. The plasmid DNA was isolated using a plasmid mini kit from Qiagen. Minipreps were checked for correct integration of the Ugcg oligonucleotides by PCR and consecutive sequence analysis. or Gg 4 Cer, could be verified in the neutral GSL fraction by anti GA1 immune overlay. GA1 expression was elevated in liver tumors of both Ugcg f/f -and Ugcg f/fAlbCre mice ( Figure 4A). (B) , gangliosides of the 0-series GSLs are characterized by sialic acid ornamentations on galactosamine and/or on the terminal galactose. Treatment of those GSLs with vibrio cholerae sialidase releases the neutral backbone GA1 from the 0-series gangliosides GM1b and GD1c (B). This method distinguishes 0-series gangliosides from a-, b-, and c-series derived ganglio-series gangliosides which cannot be completely cleaved with this sialidase and are negative with anti-GA1 antibodies. Sialidase treatment on the TLC plate and subsequent anti-GA1 staining confirmed the presence of GA1 and consequently the presence of 0-series derived gangliosides in the acidic GSL fraction (C). 0-series gangliosides typically can be found in mouse immune cells including bone marrow-derived DCs/macrophages (BMD-DCs) and T cells [4] , suggesting that these compounds in the tumor extracts are derived from liver infiltrating immune cells.
Transfection of Hepa cells with the Ugcg guide construct
